Granite Bio
PrivateLast Round
Series B
Apr 24, 2025
Total Funding Raised
$70M
Momentum Score
50 /100
Company Overview
Granite Bio is a biotechnology company that develops innovative monoclonal antibody treatments for autoimmune diseases aimed at depleting pathogenic cells and selectively targeting key disease biology nodes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Granite Bio Comps
Public and private peers based on sector, stage, and business model.
Granite Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 24, 2025 | ||||
| VC Round | Apr 24, 2025 |
Key People
Founding team and executive leadership
Granite Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | VC Round |
| Novartis Venture Fund | Series B, VC Round |
| Versant Ventures | Series B, VC Round |
| Sanofi Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Lead asset GRT-001 finished Phase 1a trial in healthy volunteers.
- Apr 1, 2026
Phase 1b trial for lead asset GRT-001 has started in Ulcerative Colitis patients.
Granite Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Granite Bio's valuation, stock price, and market status.
